PAR3 VARIATION IN RESOURCE UTILIZATION AND TREATMENT COSTS FOR RHEUMATOID ARTHRITIS (RA) ACROSS 5 COUNTRIES IN AN ADALIMUMAB (D2E7) CLINICAL TRIAL
Abstract
Authors
L Van de Putte R Bergemann H Rosery F Pang B Dietz H Kupper T Ashraf